Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-656: Hsa-mir-656 is a microRNA that has been studied in various contexts. It has been obtained from Dharmacon and used in experiments involving co-transfection with other microRNA mimics and inhibitors [PMC3486798]. However, when hsa-mir-656 or hsa-miR-877-5p were transfected, there was no change in luciferase activity [PMC3486798]. It was initially anticipated that hsa-mir-656 would only interact with the CBR1 3'-UTR in its rs9024 polymorphic state, but no binding capacity was observed [PMC3486798]. Bioinformatic predictions identified hsa-mir-656 as a potential candidate for interacting with the 3'-UTR of CBR1, but it had no effect on CBR1 expression or activity [PMC3486798]. Hsa-mir-656 has also been predicted to target multiple genes, including EPS15 [PMC4838358]. In glioma, hsa-mir-656 expression levels are downregulated and it inhibits neurosphere formation and cell proliferation by targeting BMPR1A [PMC5260001]. Hsa-mir-656 has also been found to play a potential role in GBM progression [PMC5260001]. Additionally, changes in expression patterns of hsa-miR-92b, hsa-miR-137, hsa-mir-656, and other miRNAs were observed after exposure to low and high doses of X-ray radiation [PMC3424689]. Hsa-mir-656 is part of an imprinted DLK-DIO3 region that comprises multiple miRNA genes [PMC3563971].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset